Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganilever vs Orgalutran in Infertility Women for Assisted Reproductive Technologies
NCT03051087Phase 4Completed
- Sponsor
- LG Chem
- Start
- Oct 2016
- Primary completion
- Mar 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ganirelix in female infertility (2 arms), sponsored by LG Chem. Primary endpoint: Number of oocytes retrieved at 10 days. Started Oct 2016; status: completed.
02
Drugs
ganirelix
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT03051087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03051087.